Inventor
MOLINO BRUCE F
US57 patents
⚠️ This page may combine multiple inventors who share the name “MOLINO BRUCE F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RHONE POULENC RORER PHARMA
10 patentsUS5064814ANov 12, 1991
Anti-thrombotic peptide and pseudopeptide derivatives
RHONE POULENC RORER PHARMA40 citations92
US5053392AOct 1, 1991
Novel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitors
RHONE POULENC RORER PHARMA45 citations92
US5332726AJul 26, 1994
Antithrombotic peptides and pseudopeptides
RHONE POULENC RORER PHARMA22 citations91
US5162336ANov 10, 1992
Tetrahydro-pyrido-indoles as cholecystokinin and gastrin antagonists
RHONE POULENC RORER PHARMA27 citations90
US5340801AAug 23, 1994
Compounds having cholecystokinin and gastrin antagonistic properties
RHONE POULENC RORER PHARMA16 citations74
US5002944AMar 26, 1991
Compounds having cardiotonic activity
RHONE POULENC RORER PHARMA10 citations74
US5780590AJul 14, 1998
Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
RHONE POULENC RORER PHARMA7 citations73
US5051405ASep 24, 1991
Anti-thrombotic peptides and pseudopeptides
RHONE POULENC RORER PHARMA13 citations73
US5866685AFeb 2, 1999
Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
RHONE POULENC RORER PHARMA3 citations63
US5258398ANov 2, 1993
Antithrombotic diaminoalkanoic acid derivatives
RHONE POULENC RORER PHARMA5 citations63
RORER PHARMACEUTICAL CORP
8 patentsUS5086069AFeb 4, 1992
Anti-thrombotic peptide and pseudopeptide derivatives
RORER PHARMACEUTICAL CORP60 citations96
US4952562AAug 28, 1990
Anti-thrombotic peptides and pseudopeptides
RORER PHARMACEUTICAL CORP57 citations95
US4859672AAug 22, 1989
Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone
RORER PHARMACEUTICAL CORP11 citations74
US4785005ANov 15, 1988
6-(6-alkylpyridone)-carbostyril compounds and their cardiotonic uses
RORER PHARMACEUTICAL CORP10 citations74
US4764512AAug 16, 1988
Benzodiazinone-pyridone compounds, cardiotonic compositions including the same, and their uses
RORER PHARMACEUTICAL CORP8 citations74
US4868300ASep 19, 1989
Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses
RORER PHARMACEUTICAL CORP5 citations63
US4906630AMar 6, 1990
Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
RORER PHARMACEUTICAL CORP3 citations59
US4785101ANov 15, 1988
Benzodiazinone-hydroxypyrazolyl compounds, cardiotonic compositions including the same and their uses
RORER PHARMACEUTICAL CORP0 citations52
PARION SCIENCES INC
7 patentsUS7247637B2Jul 24, 2007
Capped pyrazinoylguanidine sodium channel blockers
PARION SCIENCES INC81 citations99
US7868010B2Jan 11, 2011
Capped pyrazinoylguanidine sodium channel blockers
PARION SCIENCES INC50 citations98
US7807834B2Oct 5, 2010
Capped pyrazinoylguanidine sodium channel blockers
PARION SCIENCES INC49 citations98
US7410968B2Aug 12, 2008
Capped pyrazinoylguanidine sodium channel blockers
PARION SCIENCES INC61 citations98
US7388013B2Jun 17, 2008
Capped pyrazinoylguanidine sodium channel blockers
PARION SCIENCES INC58 citations98
US7368447B2May 6, 2008
Capped pyrazinoylguanidine sodium channel blockers
PARION SCIENCES INC74 citations98
US7368451B2May 6, 2008
Capped pyrazinoylguanidine sodium channel blockers
PARION SCIENCES INC74 citations98
ALBANY MOLECULAR RES INC
7 patentsUS9604960B2Mar 28, 2017
Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
ALBANY MOLECULAR RES INC28 citations93
US7696166B2Apr 13, 2010
Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
ALBANY MOLECULAR RES INC21 citations93
US7956050B2Jun 7, 2011
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ALBANY MOLECULAR RES INC13 citations81
US7632807B2Dec 15, 2009
Cyclosporin alkynes and their utility as pharmaceutical agents
ALBANY MOLECULAR RES INC6 citations73
US9499531B2Nov 22, 2016
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ALBANY MOLECULAR RES INC2 citations63
US7696165B2Apr 13, 2010
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
ALBANY MOLECULAR RES INC2 citations63
US9085531B2Jul 21, 2015
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ALBANY MOLECULAR RES INC0 citations52
AMR TECHNOLOGY INC
5 patentsUS7511013B2Mar 31, 2009
Cyclosporin analogues and their pharmaceutical uses
AMR TECHNOLOGY INC254 citations98
US7541357B2Jun 2, 2009
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
AMR TECHNOLOGY INC24 citations92
US7378391B2May 27, 2008
Cyclosporin alkyne analogues and their pharmaceutical uses
AMR TECHNOLOGY INC13 citations83
US7361636B2Apr 22, 2008
Cyclosporin alkynes and their utility as pharmaceutical agents
AMR TECHNOLOGY INC13 citations83
US7538084B2May 26, 2009
Cyclosporins
AMR TECHNOLOGY INC4 citations58
JOHNSON MICHAEL R
3 patentsUS8507497B2Aug 13, 2013
Capped pyrazinoylguanidine sodium channel blockers
JOHNSON MICHAEL R25 citations92
US8431579B2Apr 30, 2013
Capped pyrazinoylguanidine sodium channel blockers
JOHNSON MICHAEL R27 citations92
US8211895B2Jul 3, 2012
Capped pyrazinoylguanidine sodium channel blockers
JOHNSON MICHAEL R32 citations92
MOLINO BRUCE F
3 patentsUS8236796B2Aug 7, 2012
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
MOLINO BRUCE F10 citations83
US8227486B2Jul 24, 2012
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
MOLINO BRUCE F10 citations83
US8791101B2Jul 29, 2014
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
MOLINO BRUCE F1 citations59
RORER INC WILLIAM H
2 patentsUS4666913AMay 19, 1987
Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses
RORER INC WILLIAM H72 citations96
US4725686AFeb 16, 1988
Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses
RORER INC WILLIAM H4 citations63
LIU SHUANG
2 patentsRORER PHARMACEUTICAL CORPORATO
1 patentAVENTIS PHARMA INC
1 patentAVENTIS PHARM PROD INC
1 patentShowing the top 50 of 57 patents by PatentIndex Score.